Feed aggregator

GSK Wins Broad Label Expansion for Jemperli in First-Line Endometrial Cancer

Biospace news - Fri, 08/02/2024 - 02:00

Vir Lays Off 25% of Staff, Abandons Most Virus Work and Pivots to Cancer in Sanofi Deal

Biospace news - Fri, 08/02/2024 - 02:00

Vertex Scraps Two Phase I AATD Candidates Following Disappointing Data

Biospace news - Fri, 08/02/2024 - 02:00

Biopharma Layoff Tracker 2024: uniQure, Vir, Arbutus and More Cut Staff

Biospace news - Fri, 08/02/2024 - 02:00

Moderna Cuts Full-Year Revenue Guidance as COVID-19 Vaccine Sales Crater in Q2

Biospace news - Thu, 08/01/2024 - 02:00

Otsuka Pays Up to $1.1B to Buy Jnana, Adds Drug Discovery Capabilities

Biospace news - Thu, 08/01/2024 - 02:00

Lilly’s Tirzepatide Clears Phase III Cardiovascular Study on Heels of Novo

Biospace news - Thu, 08/01/2024 - 02:00

FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm

Biospace news - Thu, 08/01/2024 - 02:00

Novo Loses IRA Case as NJ Judge Asserts Price Negotiations Are Voluntary

Biospace news - Thu, 08/01/2024 - 02:00

Sanofi Sues Sarepta Over Elevidys DMD Gene Therapy, Alleges Patent Infringement

Biospace news - Thu, 08/01/2024 - 02:00

5 Quick Ways to Strengthen Your LinkedIn Profile in 60 Minutes

Biospace news - Wed, 07/31/2024 - 02:00
Companies will look at job candidates’ LinkedIn profiles, so make sure yours is strong, from the summary of your expertise and qualifications to testimonials from colleagues.

Biopharma Investment Activity Continued to Rise in Q2: J.P. Morgan

Biospace news - Wed, 07/31/2024 - 02:00

New Leqembi Data Illuminate Longer-Term Effects, Tau Reduction

Biospace news - Wed, 07/31/2024 - 02:00

GSK Lowers Full-Year Vaccine Guidance After Disappointing Q2 Sales, CDC RSV Guidelines

Biospace news - Wed, 07/31/2024 - 02:00

Vertex Nabs Priority Review for Non-Opioid Pain Drug, Awaits January 2025 Decision

Biospace news - Wed, 07/31/2024 - 02:00

Incyte Trims Early-Stage Pipeline Amid Strategic Shift in R&D

Biospace news - Wed, 07/31/2024 - 02:00

Boehringer Buys Nerio Therapeutics for $1.3B to Boost Immuno-Oncology Pipeline

Biospace news - Mon, 07/29/2024 - 02:00
Under the deal announced Monday with the California biotech, German pharma Boehringer Ingelheim is gaining access to novel immune checkpoint inhibitors designed to activate the immune system to fight cancer cells.

WuXi AppTec Hit With Slight Drop in US Revenue as Threat of BIOSECURE Act Looms

Biospace news - Mon, 07/29/2024 - 02:00

FDA Flags Safety Risks of Compounded Versions of Novo’s Semaglutide, Reports Hospitalizations

Biospace news - Mon, 07/29/2024 - 02:00

AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff

Biospace news - Mon, 07/29/2024 - 02:00